Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis

References

• Hunninghake GW, Costabel U, Ando M, . ATS/ERS/WASOG statement on sarcoidosis [American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders]. Sarcoidosis Vasc Diffuse Lung Dis 1999;16: 149–53
   PubMed Web of Science ®Google Scholar
• Freeman BA, Transwell AK. Biochemical and cellular aspects of pulmonary oxygen toxicity. Adv Free Rad Biol Med 1985;1: 133–64
   Google Scholar
• Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988;63: 390–8
   PubMed Web of Science ®Google Scholar
• Riley DJ, Kerr JS. Oxidant injury of the extracellular matrix: potential role in the pathogenesis of pulmonary emphysema. Lung 1985;163: 1–13
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE, Pierson G, . Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. J Lab Clin Med 1998;111: 399–404
   Google Scholar
• Fels AO, Nathan CF, Cohn ZA. Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons αA, β, and γ and 1, 25-dihydroxyvitamin D3. J Clin Invest 1987;80: 381–6
   PubMed Web of Science ®Google Scholar
• Psathakis K, Papatheodorou G, Plataki M, . 8-isoprostane, a marker of oxidative stress, is increased in expired breath condensate of patients with pulmonary sarcoidosis. Chest 2004;125: 1005–11
   PubMed Web of Science ®Google Scholar
• Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica 1990;20: 901–7
   PubMed Web of Science ®Google Scholar
• Romero FJ, Bosch-Morell F, Romero MJ, . Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998;106: 1229–34
   PubMed Web of Science ®Google Scholar
• Fridovich I, Freeman BA. Antioxidant defenses in the lung. Annu Rev Physiol 1986;48: 693–702
   PubMed Web of Science ®Google Scholar
• Halliwell B. How to characterize a biological antioxidant. Free Rad Res Commun 1990;9: 1–32
   PubMed Web of Science ®Google Scholar
• Maier KL. How the lung deals with oxidants. Eur Respir J 1993;6: 334–6
   PubMed Web of Science ®Google Scholar
• Nofer JR, Kehrel B, Fobker M, . HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002;161: 1–16
   PubMed Web of Science ®Google Scholar
• Sugano M, Tsuchida K, Makino N. High-density lipoprotens protect endothelial cells from tumor necrosis factor-a-induced apoptosis. Biochem Biophys Res Commun 2000;272: 872–6
   PubMed Web of Science ®Google Scholar
• La Du BN. Human serum paraoxonase/arylesterase. Pharmacogenetics of drug metabolism. In: W Kalow, editor. Pergamon Press; New York: 1992:51–91
   Google Scholar
• Watson AD, Berliner JA, Hama SY, . Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96: 2882–91
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Iguchi K, Nakajima T, . Glycated high-density lipoprotein induces apoptosis of endothelial cells via a mitochondrial dysfunction. Biochem Biophys Res Commun 2001;287: 714–20
   PubMed Web of Science ®Google Scholar
• Okhawa H, Ohshi N, Yagi K. Assay or lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95: 351–8
   PubMed Web of Science ®Google Scholar
• Hasselwander O, Savage DA, McMaster D, . Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 1999;56: 289–98
   PubMed Web of Science ®Google Scholar
• Saha N, Roy AC, Teo SH, . Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991;40: 277–82
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18: 499–502
   PubMed Web of Science ®Google Scholar
• Biemond P, Swaak AJ, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum 1984;27: 760–5
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Lunec J. The C1q binding activity of IgG is modified in vitro by reactive oxygen species: implications for rheumatoid arthritis. FEBS Lett 1996;388: 161–4
   PubMed Web of Science ®Google Scholar
• Nurcombe HL, Bucknall RC, Edwards SW. Activation of the neutrophil myeloperoxidase – H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis. Ann Rheum Dis 1991;50: 237–42
   PubMed Web of Science ®Google Scholar
• Blake DR, Merry P, Unsworth J, . Hypoxic reperfusion injury in the inflamed human joint. Lancet 1989;11: 289–93
   Google Scholar
• Rozenberg O, Rosenblat M, Coleman R, . Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knock out mice. Free Radical Biol Med 2003;34: 774–84
   PubMed Web of Science ®Google Scholar
• Nielsen H, Frederiksen J, Sherson D, . Comparison of alveolar macrophage and blood monocyte oxidative burst response in pulmonary sarcoidosis. APMIS 1990;98: 401–6
   PubMed Web of Science ®Google Scholar
• Ayub A, Mackness MI, Arrol S, . Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19: 330–5
   PubMed Web of Science ®Google Scholar
• Mackness MI, Harty D, Bhatnagar D, . Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus. Atherosclerosis 1991;86: 193–9
   PubMed Web of Science ®Google Scholar
• Araki S. Receptor-mediated O2− release by alveolar macrophages and peripheral blood monocytes from smokers and nonsmokers: priming and triggering effects of monomeric IgG, concanavalin A, N-formyl-methionylleucyl- phenylalanine, phorbol myristate acetate, and cytochalasin D. Am Rev Respir Dis 1987;136: 310–5
   PubMed Web of Science ®Google Scholar
• Martin RR, Lawrence EC, Teague RB, . Chemiluminescence of lung macrophages and blood leukocytes in sarcoidosis. Am Rev Respir Dis 1986;133: 298–301
   PubMed Web of Science ®Google Scholar
• Fridovich I, Freeman BA. Antioxidant defenses in the lung. Annu Rev Physiol 1986;48: 693–702
   PubMed Web of Science ®Google Scholar
• Maier KL. How the lung deals with oxidants. Eur Respir J 1993;6: 334–6
   PubMed Web of Science ®Google Scholar
• Cantin AE, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139: 370–2
   PubMed Web of Science ®Google Scholar
• Cantin AE, North SL, Hubbard RC, . Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987;63: 152–7
   PubMed Web of Science ®Google Scholar
• Pacht ER, Kaseki H, Mohammed JR, . Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J Clin Invest 1986;77: 789–96
   PubMed Web of Science ®Google Scholar
• Mango GW, Johnston CJ, Reynolds SD, . Clara cell secretory protein deficiency increases oxidant stress response in conducting airways. Am J Physiol 1998;275: L348–L356
   PubMed Web of Science ®Google Scholar
• Rodrigo L, Hernandez AF, Lopez-Caballero JJ, . Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue implications for its physiological role. Chem Biol Interact 2001;137: 123–37
   PubMed Web of Science ®Google Scholar
• Schiavon R, Battaglia P, De Fanti E, . HDL3-related decreased serum paraoxonase (PON1) activity in uremic patients: compression with the PON1 allele polymorphism. Clin Chim Acta 2002;324: 39–44
   PubMed Web of Science ®Google Scholar
• Boemi M, Sirolla C, Testa R, . Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients. Diabetic Med 2004;21: 423–7
   PubMed Web of Science ®Google Scholar
• James RW, Leviev I, Righetti A. Smoking is associated with reduced paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000;101: 2252–7
   PubMed Web of Science ®Google Scholar
• Isik B, Isik RS, Ceylan A, . Trace elements and oxidative stress in chronic obstructive pulmonary disease. Saudi Med J 2005;26: 1882–5
   Google Scholar
• Pryor WA, Stoen K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993;686: 12–27
   PubMed Web of Science ®Google Scholar
• Salazar A, Mana J, Pinto X, . Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis. Atherosclerosis 1998;136: 133–7
   PubMed Web of Science ®Google Scholar
• Salazar A, Mana J, Fiol C, . Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis 2000;152: 497–502
   PubMed Web of Science ®Google Scholar
• Kindman LA, Gilbert HS, Almenoff JS, . High-density lipoprotein cholesterol is reduced in patients with sarcoidosis. Am J Med 1989;86: 376–8
   PubMed Web of Science ®Google Scholar
• Salazar A, Mana J, Pinto X, . Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clin Chim Acta 2002;320: 59–64
   PubMed Web of Science ®Google Scholar